• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-120-PTX
Device Problem Occlusion Within Device (1423)
Patient Problems Stenosis (2263); Claudication (2550)
Event Date 08/05/2013
Event Type  Injury  
Manufacturer Narrative
(b)(4).Pma/510(k) # p100022/s001 niu.The ziv6-35-125-6.0-120-ptx stent of lot number c778923 was implanted in the patient and is therefore unavailable for evaluation.With the information provided a document based investigation was carried out.It is known that the patient had the following pre-existing conditions: hypertension & smoking.It was stated by the originator that there is no imaging available for review.There is no evidence to suggest that this event did not occur, therefore the complaint is confirmed based on customer testimony.Restenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting).Vessel injury provokes an inflammatory response that leads to (or amplifies) the restenosis process.It may be noted that surface of the zilver ptx stent is coated with the drug (paclitaxel) to help prevent subsequent restenosis of the artery.In addition worsened claudication was also observed on the patient.It can be noted that this symptom indicates progression of peripheral artery disease and can also be associated with the restenosis process.It can be therefore stated that it is unlikely that the reported restenosis could have occurred due to zilver ptx malfunction; however as no imaging was available, a definitive root cause of this event cannot be determined.It may be noted that as per the packaging insert, restenosis of the stented artery is a known potential adverse event associated with the placement of this device.As per the packaging insert, worsened claudication is also a potential adverse event related to the placement of this device.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.A review of the relevant manufacturing records revealed no discrepancies that could have contributed to this complaint.Upon review of complaints, this failure mode has occurred previously with the lot number c778923.However, based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with the lot number c778923.Pta was performed was required as a result of this occurrence.The patient's condition has been recovered.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Event Description
On (b)(6) 2012: ziv6-35-125-6.0-120-ptx (c778923) was placed in the patient's right upper sfa.On (b)(6) 2013: restenosis (50-99%) in the lesion was confirmed.Worsen claudication was observed on the patient.On (b)(6) 2013: pta was performed.The patient's condition has been recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer Contact
tracy o'sullivan
o'halloran road
national technology park
limerick 
061334440
MDR Report Key6559641
MDR Text Key74894400
Report Number3001845648-2017-00168
Device Sequence Number1
Product Code NIU
UDI-Device Identifier10827002513454
UDI-Public(01)10827002513454(17)140426(10)C778923
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 04/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/11/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberZIV6-35-125-6.0-120-PTX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date05/11/2017
Event Location Hospital
Date Manufacturer Received04/13/2017
Date Device Manufactured06/21/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
-
-